Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 1
1988 1
1995 1
1999 2
2004 1
2007 2
2010 1
2011 2
2012 3
2013 3
2014 2
2015 1
2016 1
2018 1
2019 2
2021 1
2022 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

22 results

Results by year

Filters applied: . Clear all
Page 1
Childhood Myelodysplastic Syndrome.
Chisholm KM, Bohling SD. Chisholm KM, et al. Clin Lab Med. 2023 Dec;43(4):639-655. doi: 10.1016/j.cll.2023.06.005. Epub 2023 Aug 7. Clin Lab Med. 2023. PMID: 37865508 Review.
Childhood myelodysplastic syndrome.
Chatterjee T, Choudhry VP. Chatterjee T, et al. Indian J Pediatr. 2013 Sep;80(9):764-71. doi: 10.1007/s12098-013-1130-8. Epub 2013 Aug 3. Indian J Pediatr. 2013. PMID: 23912822 Review.
Myelodysplastic syndrome in a child with 15q24 deletion syndrome.
Narumi Y, Shiohara M, Wakui K, Hama A, Kojima S, Yoshikawa K, Amano Y, Kosho T, Fukushima Y. Narumi Y, et al. Am J Med Genet A. 2012 Feb;158A(2):412-6. doi: 10.1002/ajmg.a.34395. Epub 2011 Dec 2. Am J Med Genet A. 2012. PMID: 22140075
We report on a 13-year-old boy with this syndrome manifesting childhood myelodysplastic syndrome (MDS). He had characteristic facial features, hypospadias, and mild developmental delay. ...
We report on a 13-year-old boy with this syndrome manifesting childhood myelodysplastic syndrome (MDS). He had characte …
Loss of B cells and their precursors is the most constant feature of GATA-2 deficiency in childhood myelodysplastic syndrome.
Nováková M, Žaliová M, Suková M, Wlodarski M, Janda A, Froňková E, Campr V, Lejhancová K, Zapletal O, Pospíšilová D, Černá Z, Kuhn T, Švec P, Pelková V, Zemanová Z, Kerndrup G, van den Heuvel-Eibrink M, van der Velden V, Niemeyer C, Kalina T, Trka J, Starý J, Hrušák O, Mejstříková E. Nováková M, et al. Haematologica. 2016 Jun;101(6):707-16. doi: 10.3324/haematol.2015.137711. Epub 2016 Mar 24. Haematologica. 2016. PMID: 27013649 Free PMC article.
Prospective validation of the provisional entity of refractory cytopenia of childhood, proposed by the World Health Organization.
Hama A, Hasegawa D, Manabe A, Nozawa K, Narita A, Muramatsu H, Kosaka Y, Kobayashi M, Koh K, Takahashi Y, Watanabe K, Ohara A, Ito M, Kojima S. Hama A, et al. Br J Haematol. 2022 Feb;196(4):1031-1039. doi: 10.1111/bjh.17921. Epub 2021 Nov 3. Br J Haematol. 2022. PMID: 34729770
In 2008, the World Health Organization proposed a new entity of childhood myelodysplastic syndrome (MDS), which was referred to as refractory cytopenia of childhood (RCC). ...
In 2008, the World Health Organization proposed a new entity of childhood myelodysplastic syndrome (MDS), which was ref …
Wilms' tumor 1 mRNA expression: a good tool for differentiating between myelodysplastic syndrome and aplastic anemia in children?
Zuo Y, Cheng Y, Zhang L, Qin Y, Luo H. Zuo Y, et al. Hematology. 2019 Dec;24(1):480-486. doi: 10.1080/16078454.2019.1631507. Hematology. 2019. PMID: 31210595 Clinical Trial.
Objectives: To evaluate the value of Wilms' tumor 1 mRNA (WT1) expression in the differential diagnosis of childhood myelodysplastic syndrome (MDS) and aplastic anemia (AA). ...
Objectives: To evaluate the value of Wilms' tumor 1 mRNA (WT1) expression in the differential diagnosis of childhood myelodysplast …
22 results